Wan S, LeClerc J L, Vincent J L
Department of Cardiac Surgery, University Hospital Erasme, Free University of Brussels, Belgium.
Ann Thorac Surg. 1997 Jan;63(1):269-76. doi: 10.1016/s0003-4975(96)00931-9.
A growing body of evidence relates the release during cardiopulmonary bypass (CPB) of proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8, to the postoperative systemic inflammatory response syndrome. Antiinflammatory cytokines, such as IL-10, however, may also play an important role in limiting these complications.
The English-language literature was reviewed. Emphasis was placed on cytokine responses during clinical CPB for cardiac operations and, in particular, for heart and heart-lung transplantation.
The recent data indicate that (1) although cytokine release can be triggered by many factors during CPB, ischemia-reperfusion may play the most important role; (2) the levels of tumor necrosis factor-alpha, IL-6, and IL-8 are correlated with the duration of cardiac ischemia and the myocardium is a major source of these three cytokines during CPB; (3) IL-10 levels are correlated with the duration of CPB and the liver is a major source of IL-10 during CPB; and (4) steroid pretreatment is an effective intervention to inhibit the release of proinflammatory cytokines and enhance IL-10 production.
The improved knowledge of cytokine responses to CPB may help to develop interventions aimed at reducing postoperative morbidity and mortality.
越来越多的证据表明,在体外循环(CPB)期间释放的促炎细胞因子,如肿瘤坏死因子-α、白细胞介素(IL)-6和IL-8,与术后全身炎症反应综合征有关。然而,抗炎细胞因子,如IL-10,可能在限制这些并发症方面也起重要作用。
回顾了英文文献。重点关注心脏手术,特别是心脏和心肺移植的临床CPB期间的细胞因子反应。
最近的数据表明:(1)尽管在CPB期间细胞因子释放可由多种因素触发,但缺血-再灌注可能起最重要作用;(2)肿瘤坏死因子-α、IL-6和IL-8的水平与心脏缺血持续时间相关,且在CPB期间心肌是这三种细胞因子的主要来源;(3)IL-10水平与CPB持续时间相关,且在CPB期间肝脏是IL-10的主要来源;(4)类固醇预处理是抑制促炎细胞因子释放并增强IL-10产生的有效干预措施。
对CPB细胞因子反应的深入了解可能有助于制定旨在降低术后发病率和死亡率的干预措施。